TruthArchive.ai - Related Video Feed

The transcript discusses several intertwined points about the FDA's funding, information sources, and a personal health journey. It states that the FDA gets 47% of its funding from the pharmaceutical industry, and that this information was released only after a rumor claimed 50% of their funding came from big pharma. The speaker notes, “the people that you’re supposed to be making rules and regulations for are the same people that are paying you money,” describing this as a conflict of interest and urging readers to consider the implication of funding influencing regulatory decisions. The speaker then shifts to their personal experience with health issues and the challenge of finding valid information that isn’t paid for by big pharma. They share a statistic attributed to women with similar issues: “85 to ninety percent of the women who experience the same issues that I experience notice changes in their symptoms or alleviation completely from their symptoms simply by changing their diet, namely going gluten free.” Although the speaker says they personally are not inclined to adopt gluten-free changes, they are cutting out refined carbs and sugars from their diet and report progress: “I've been on this diet for two days now, and I already feel a ton different.” This personal anecdote is presented in the context of comparing diet-driven symptom changes to pharmaceutical influence. The speaker mentions ongoing changes to their living space and routines as part of their broader stance. They say, “we're putting up our squat rack again in our home gym,” signaling a strengthening or lifestyle shift. They also report, “we did get some egg laying birds,” suggesting new household activities. Throughout, there is a reiterated sentiment directed at big pharma: “basically saying a big to big pharma,” underscoring their stance against pharmaceutical influence. Finally, the speaker emphasizes the surprising nature of the 47% funding figure and reiterates, “I still can't believe it's 47% of their funding, and they think that's okay.” They invite audience engagement, closing with, “as always, I look forward to hearing your thoughts about all of this down below.”

The speaker discusses the pharmaceutical industry and its problems. They explain that the industry has struggled to keep up with advancements in molecular biology and the changing face of capitalism. The speaker highlights how the industry has become powerful and profitable by increasing drug prices and creating "me too" drugs with slight variations to extend patents. They criticize the lack of transparency and the influence of the pharmaceutical industry on decision-making at international and national levels. The speaker emphasizes the need for better pharmacovigilance and the importance of educating doctors about the risks and benefits of medications. They also mention the need for better reporting and understanding of adverse effects. The speaker concludes by stating that changes are needed in medical education and the way medications are developed and prescribed.

There are 1,800 big pharma lobbyists in Washington, influencing policies significantly. This raises concerns about their impact on public health and safety. To combat this, one solution is to prohibit government officials from becoming lobbyists after their term. Currently, there are regulations that limit this, but they often allow for loopholes, enabling former officials to work for companies they once regulated. This creates conflicts of interest, as seen with the Sackler family and the FDA. While addressing these issues is crucial, it often gets sidelined by other pressing matters.

The speaker discusses the pharmaceutical industry and its problems. They explain that the industry has struggled to keep up with the complexity of molecular biology and the changing face of capitalism. The speaker highlights how the industry has become powerful and profitable by increasing prices and creating "me too" drugs. They criticize the lack of transparency and the influence of the industry on decision-making at various levels. The speaker emphasizes the need for better pharmacovigilance and a change in medical education to prioritize understanding the dangers of medications. They also address concerns about the industry and the role of doctors.

The FDA receives significant funding from Big Pharma through the Prescription Drug User Fee Act, leading to potential conflicts of interest. Lobbying efforts have hindered drug price negotiation and transparency. The Act's impact on FDA warning letters coincided with the Vioxx scandal. Former FDA officials often transition to pharmaceutical companies, raising concerns about regulatory integrity. Despite past controversies, trust in the industry and regulators is emphasized, despite their substantial profits.

It used to be that pharmaceutical companies were working with the doctors. Now unfortunately, companies are captured by the price of the stock. Know, venture capitalist owned pharmaceutical companies. They owned the CR or the clinical research organizations. They owned the site. They owned the institutional review board. They owned the advertising, the marketing. They influenced through the media. And so unfortunately, there's a big it's a it's a loaded question, but it's a big market. And what we saw this pandemic was the price of the stock mattered more than the price of a life.

Dr. Jean-Yves Ral, a little-known figure to the public, was a powerful cardiologist who held control over various regional health agencies. He was feared for his extensive authority and made decisions that some found peculiar. Known for his close ties to those in power, he didn't hesitate to fire those who stood in his way. Despite the difficulty, he agreed to this interview for the sake of his three children. However, since February 2023, Dr. Jean-Yves Ral and his two closest collaborators have faced legal trouble for alleged conflicts of interest at the Auvergne-Rhône-Alpes Regional Health Agency. This investigation delves into the man nicknamed the true Health Minister.

I'm an investigative reporter who initially trusted the medical establishment, but I've uncovered conflicts of interest and financial incentives that corrupt health research. The pharmaceutical industry legally launders taxpayer money through universities to produce unchallenged, biased studies. For example, a researcher who found a chemical feminizing frogs faced immense pressure to suppress his findings. Scientific journals are also compromised; former editors admit they couldn't stop industry-tainted studies. Drug companies ghostwrite articles for doctors to promote their products. They also influence medical schools, doctor education, media, and federal agencies, prioritizing profit over public health. This has led to a rise in chronic diseases, especially among children, that the medical establishment largely ignores. There's pressure to normalize these outcomes rather than address the root causes, as that is more profitable. Informed consent is also threatened, with the FDA loosening requirements for disclosing study risks.

Government regulators are influenced by big pharma, with FDA employees receiving royalties from approved vaccines and drugs. FDA's budget heavily relies on pharmaceutical industries, leading to agency capture. For instance, NIH owns half of the Moderna vaccine, with high-level deputies under Fauci receiving $150,000 annually from it indefinitely. This conflict of interest is not widely discussed in mainstream media, as speaking out can lead to censorship.

Universities, health organizations, and other institutions are in need of funding, while big multinational corporations have the money to provide it. These corporations use their financial influence to gain control. They give grants for research, collaborate on projects, and pay individual professors, doctors, and researchers. They may also fund educational programs that align with their interests. Although these arrangements are supposed to be independent, it is clear that corporations prioritize supporting their own products. If organizations do not comply, they risk losing funding. This financial influence is how the medical establishment is swayed.

There is a lot of corruption in politics due to money, bribes, and backdoor deals. One major mistake was allowing drug companies to advertise on television, which only two countries, the United States and New Zealand, permit. These commercials often make exaggerated claims and list potential side effects very quickly. It's concerning how they can make something seem great one moment and then mention serious side effects like suicidal thoughts and rectal bleeding. Personally, I haven't taken many medications, but when I tried SSRIs, I found the last 20 seconds of the commercial more impactful than the rest, and I didn't experience any benefits from them.

Politicians have long promised to eliminate the discrepancy between drug prices in the U.S. and Europe. This was a key issue for Bernie Sanders, but previous leaders haven't acted on it. Politicians make these promises knowing they likely won't have to fulfill them. The reason is that Congress is heavily influenced by the pharmaceutical industry. There is at least one pharmaceutical lobbyist for every congressman, senator, and Supreme Court member.

We're paying too much for drugs compared to other countries, and existing laws make it hard to lower costs. The middlemen in the drug industry are profiting significantly without adding value. We're going to eliminate these middlemen to reduce drug prices to unprecedented levels. This topic dominated our discussions with executives and others involved.

Public health officials may not always prioritize our best interests. Parents should make their own decisions. Doctors should be open to learning about life-saving options. The pharmaceutical industry heavily influences medical education and the healthcare system. We need doctors to prioritize children's well-being over profits, even if it means taking a financial hit.

Universities, health organizations, and others seek money from big corporations to influence research and opinions. By funding research, paying individual professionals, and supporting programs, corporations ensure loyalty and favorable outcomes. This financial influence shapes the medical establishment, even if it appears independent on the surface.

Drug companies are the wealthiest businesses and buy influence, including ministers of health. They target professors and chiefs of departments to become key opinion leaders who indoctrinate other doctors to use expensive drugs over cheaper alternatives. Medical education is partly corrupted. Doctors should avoid educational events funded by the drug industry, as key opinion leaders are selected for their sales abilities. Denmark is considered one of the least corrupt countries, but its healthcare system is corrupt. In Denmark, thousands of doctors are on drug company advisory boards or consult, which is how influence and loyalty are bought. Many of these doctors don't do much but are being bought.

Pharmaceutical companies like Merck, Sanofi, Pfizer, and Glaxo have paid billions in penalties for dishonest practices, resulting in harm and deaths. The opioid crisis and Vioxx are examples of collusion between pharma and regulators, leading to thousands of deaths. Regulatory agencies have become puppets for the industry, depriving the public of informed consent.

Most physicians and clinicians avoid getting involved in the issue of profit-driven healthcare. The real problem lies in the collusion between academic institutions, doctors, medical journals, and industry for financial gain. These corporations, as legal entities, often exhibit psychopathic traits, prioritizing profit over the well-being of patients. Many top drug companies have been fined billions for illegal marketing, hiding harm data, and manipulating results. However, these fines are often outweighed by the profits they make from selling the drugs. While the pharmaceutical industry has contributed life-saving treatments, the net effect of their practices is negative, with a significant amount of wasted resources and harmful drugs approved.

Politicians have long promised to address the discrepancy between drug prices in the U.S. and Europe. This issue was central to Bernie Sanders' presidential campaigns. However, these promises were never fulfilled because Congress is heavily influenced by the pharmaceutical industry. There is at least one pharmaceutical lobbyist for every member of Congress, the Senate, and the Supreme Court.

The discussion traces a long, shadowy arc in the development of modern vaccines and medicine, arguing that rapid COVID-19 vaccine progress rests on over a century of influence by powerful interests rather than sudden breakthroughs. - The narrative centers on John D. Rockefeller, who became America’s first billionaire in 1913, the same year the Federal Reserve was created. It frames Rockefeller as leveraging his oil wealth to monopolize medicine, promoting prescription drugs while vilifying natural and holistic remedies. The claim is that Rockefeller used strategic philanthropy (Rockefeller Institute for Medical Research, established 1901; Rockefeller Foundation, 1913) to push laboratory-based, drug-centered medicine, marginalize herbalism and naturopathy, and steer doctors toward pharmaceuticals. The effect, according to the speakers, was to keep people sick so they would return for ongoing treatments rather than cures. - The timeline continues with the rise of the pharmaceutical industry from the 1920s to 1940s, described as moving into synthetic drugs with Rockefeller guidance. Natural remedies were said to be non-patentable while synthetic drugs could be patented, creating a business incentive for ongoing, chronic treatment rather than cures. - The conversation shifts to regulatory dynamics, arguing that regulation became regulatory capture from the 1930s to 1960s, with the FDA functioning as a gatekeeper increasingly populated by former pharma professionals. The FDA’s integrity is debated through the example of Dr. Francis Kelsey, who resisted approving thalidomide; the drug was later linked to birth defects worldwide, and Kelsey’s stance is presented as a rare early stand for public safety. - In the 1970s and 1980s, the narrative asserts growing corporate influence: pharma lobbies expand, advertising budgets explode, and medicine becomes a growth industry. The Bayh-Dole Act of 1980 is cited as enabling private patents on publicly funded research, tying universities to pharma interests and shaping medical education toward pharmaceutical solutions. Direct-to-consumer advertising is highlighted as a turning point in the 1990s, pressuring doctors through patient demand spurred by TV ads. - The discussion includes a first-hand account from a former pharmaceutical sales representative, Lisa Prada, who describes bribes and perks (golf outings, concerts, strip clubs, etc.) to influence prescribing, and asserts that patients were often treated as means to corporate ends. - Kim Bright, founder of Brightcore Nutrition, joins to discuss current health issues, arguing that the pharmaceutical industry prioritizes profits over patient well-being. She notes that the Rockefeller Foundation funded COVID-19 vaccine efforts (she cites $55 million) and argues the foundation and industry continued to push medical interventions globally. She notes that the FDA’s public acknowledgment of COVID vaccine-related child deaths is incongruent with whistleblowers’ claims and autopsy data. - The program underscores the idea that prescription drugs are the third leading cause of death in the United States and Europe, citing studies on gut microbiome disruption from medications like antibiotics and acid-reducing drugs (dysbiosis) as a major contributor to chronic disease. - The gut microbiome is emphasized as central to health. Dr. David Perlmutter’s work on the gut-brain connection is referenced, including criticism faced for linking diet and fermented foods to health outcomes. Kimchi is highlighted as a powerful antimicrobial and a potential anti-aging agent in cellular studies. The hosts discuss kimchi’s health benefits, including improved digestion, immune function, and weight management. - Brightcore promotes Kimchi One capsules as a convenient alternative for Americans who dislike traditional kimchi, claiming benefits such as reduced bloating, better digestion, improved hair and skin, and weight loss. A discount offer is advertised: 25% off online, up to 50% off with a phone order, free shipping, and a free vitamin D3 with the first 100 callers, using the code provided. - The conversation closes with reflections on the do-not-mistake-the-system dynamic, optimism about changes in medicine, and calls for removing dependency on processed foods and advertising-driven medicine, with an acknowledgment of RFK Jr.’s activism against pharmaceutical ads on television.

French journalists investigate the dangers and insufficient testing of medications on the market. The pharmaceutical lobby works hard in the political arena to quickly bring drugs to market. Doctors and pharmaceutical companies are forming closer ties. Shortly after, many parliamentarians from around the world call for vaccination against cervical cancer. The European Medicines Agency provides advice to the European Commission on whether a drug should be allowed in Europe.

Conflicts and controversies surrounding remdesivir are significant. In November 2020, the World Health Organization conducted a comprehensive study and advised against using remdesivir in hospitals due to its association with death and kidney and liver injuries. Despite this, the U.S. incentivizes its use by offering hospitals a 20% bonus on the total bill if remdesivir is administered. As a doctor, I find it troubling that while other medications do not provide such financial incentives, the use of remdesivir can lead to substantial additional costs for hospitals, contradicting the WHO's recommendations. This situation highlights a serious disconnect in medical decision-making.

Hi. I'm Robert F. Kennedy Jr, your HHS secretary. Should doctors make decisions based upon what's best for their patients or based upon what makes them the most money? It rewards certain treatments, not because they're better for the patient, but because someone profits. Take what happened during COVID. Hospitals were paid to report staff vaccination rates. We're scanning every corner of the health care system for hidden incentives at corrupt medical judgment. What we're finding is alarming. Doctors are being paid to vaccinate not to evaluate. We've recently uncovered that more than 36,000 doctors had their Medicare reimbursements altered based upon childhood vaccination rates. That's not medicine.